HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

No effect of desmopressin administration before kidney biopsy on the risk of major post-biopsy bleeding.

AbstractBACKGROUND/AIMS:
The most important complication of kidney biopsy is bleeding, and it is unclear whether desmopressin is effective in preventing it. Thus, the study was conducted to compare post-biopsy bleeding with or without desmopressin prescription prior to percutaneous kidney biopsy.
METHODS:
In this single-centered, retrospective, and observational study, 3,018 adult patients who underwent kidney biopsy between January 1, 2003 and March 31, 2019 at our institute were recruited. Of these, 776 patients received desmopressin. To compare the differences in major bleeding events between patients administered and not administered with desmopressin, propensity score matching was performed.
RESULTS:
Before propensity score (PS) matching, it was observed that patients in the desmopressin group were significantly older (p<0.001) and had a higher blood pressure (p<0.001), higher serum creatinine (p<0.001), lower hemoglobin levels (p<0.001), and lower platelet counts (p=0.001) than those in the no-desmopressin group. Furthermore, the incidence of renal artery embolization was not significantly different between the two groups (p=0.077); however, blood transfusions occurred significantly more frequently in the desmopressin group (p<0.001). A comparison of the two groups after PS matching did not reveal any differences in the incidence of renal artery embolization (p=0.341), blood transfusion (p=0.579), and total major bleeding events (p=0.442). Furthermore, there was no difference in the incidence of perinephric hematoma on computed tomography or ultrasound (p=0.120).
CONCLUSIONS:
We do not recommend desmopressin administration before kidney biopsy.
AuthorsMinseon Cheong, Tae Yeon Lee, Jongmin Lee, Soon Bae Kim
JournalNefrologia (Nefrologia (Engl Ed)) 2022 Jan-Feb Vol. 42 Issue 1 Pg. 33-40 ISSN: 2013-2514 [Electronic] Spain
PMID36153897 (Publication Type: Journal Article, Observational Study)
CopyrightCopyright © 2022. Published by Elsevier España, S.L.U.
Chemical References
  • Hemoglobins
  • Creatinine
Topics
  • Adult
  • Biopsy (adverse effects)
  • Creatinine
  • Hemoglobins
  • Hemorrhage (chemically induced)
  • Humans
  • Kidney (pathology)
  • Retrospective Studies

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: